CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

Similar documents
BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

KNR Constructions Robust Performance on Execution Ramp-up

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Punjab National Bank

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

Buy Rating as per Mid Cap 12months investment period

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

Financial summary. Year

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

HDFC Bank (HDFCB IN) Continue to perform strong

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

Punjab National Bank

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Punjab National Bank

Bank of Baroda (BOB)

State Bank of India (SBI) Banking BUY RETAIL EQUITY RESEARCH

Manappuram Finance (MGFL IN) Healthy operating performance

ICICI Bank (ICICIBC IN) Strong improvement in asset quality

BUY Rating as per Largecap 12months investment period

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

DCB Bank Ltd. 1 P a g e

State Bank of India (SBI)

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Key estimate revision. Financial summary. Year

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Punjab National Bank

Punjab National Bank

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Punjab National Bank

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

ICICI BANK PRICE: RS.277 TARGET PRICE: RS.400 FY17E P/E: 11.2X, P/ABV: 1.7X. Q2FY16 results: Earnings in line; slippages remained elevated

Federal Bank BUY RETAIL EQUITY RESEARCH

Karur Vysya Bank (KVB) KVB IN; KVB.BO

Valuation and Outlook. Growth (%) PAT (Rs cr)

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

LIC Housing Finance. Source: Company Data; PL Research

2,09,057 1,85,859 2,17, (4.1) NIM

AXIS BANK PRICE: RS.581 TARGET PRICE: RS.685 FY17E P/E: 13.7X, P/ABV: 2.5X

Recommendation BUY Snapshot CMP (01/08/2011) Rs. 85 Target Rs. 129

Ujjivan Financial Services Ltd Banking/Finance BUY RETAIL EQUITY RESEARCH

Punjab National Bank

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research

Transcription:

4QFY18 Result Update May 28, 218 Market Cap. (Rs bn) 384 Free Float 36 Shares O/S (mn) 2,646 Improving Outlook; Maintain (BoB) has reported elevated fresh slippages of Rs125.7bn (+123% QoQ and +28% YoY) in 4QFY18, led by accelerated NPA recognition of Rs42.7bn from loan under dierent restructuring schemes of the RBI. Further, the Bank has improved its PCR including technical write o to 67.2% and 55.2% on all accounts referred to NCLT by the RBI, which will give muchneeded support to its future credit cost trajectory. Further, sharp rise in slippages led to higher interest reversal for which the Bank witnessed decline in NII and NIM during the quarter. This along with higher provisioning led to loss of Rs31bn in 4QFY18 vs. profit of Rs1.4bn in 4QFY17 and Rs1.1bn in 3QFY18. On the other hand, its domestic loan book grew by 18% YoY and 15.4% QoQ, led by a strong 52.6% YoY growth in Retail loans and continued healthy 27.7% YoY growth in Large & Medium Corporate segment. Management Commentary & Guidance Despite huge fresh slippages during the quarter, the Bank still has ~Rs1.4bn (2.2% of loan book) of standard non-retail stressed accounts, which along with reported gross NPA ratio of 12.3% takes its total stressed assets pool to 14.5% of loan book. Higher provisioning during 4QFY18 and FY18 aided the Bank to maintain its PCR excluding technical written-o accounts at 58.4% vs. 57.7% in Mar 17 and 52.1% in Mar 16. The Bank pegs credit cost at <1bps for FY19E vs. 348bps in FY18 and 189bps in FY17. On corporate slippages front, the Bank does not expect it to cross Rs1bn-mark in FY19E. Treasury performance was absolutely magnificent, as the Bank has one of the lowest modified durations (1.44 years) for its AFS book in volatile interest rate scenario. Thus, the Bank did not require availing the benefit of RBI dispensation with regard to MTM losses. Revamping of Home Loan portfolio has started paying o, which is evident from an impressive 48.2% YoY and 16.7% QoQ growth in loan portfolio in 4QFY18. Notably, the Bank is the first PSB to launch risk-based pricing on home loan with interest rate as low as 8.3%. The Management continues to expect domestic loan book to grow by 15-2% in FY19E. Outlook & Valuation Strong improvement on all major operating metrics clearly suggests that Bank s organisational transformation eort is yielding the desired outcome. Further, analysis of stressed assets clearly suggests that the Bank is approaching the end of recognition of stressed loan cycle, which along with higher PCR clearly indicates sharp moderation in credit cost from FY19E onwards. The Bank s new management is gradually reinstating confidence through major changes in operating structure, which may start yielding favourable outcome. As we believe that improved outlook on asset quality and operating performance front augurs well for the Bank, we maintain our recommendation on the stock with a down wised revised Target Price of Rs192 (from Rs27 earlier) based on x of FY2E Adjusted book value. Key Financials FY17 FY18 FY19E FY2E Loan & Advances 3,832,592 4,274,318 4,84,665 5,469,952 Net Interest Income 135,134 155,218 191,169 219,14 PPP ex Except. Items 19,751 12,56 149,492 172,215 Reported Profits 13,831 (24,318) 41,334 65,747 Earnings Per Share (Rs) 6. (9.2) 15.6 24.8 P/E (x) 24.3 (15.8) 9.3 5.9 Adj. BV (Rs) 119.8 88.5 14.1 127.7 P/ABV (x) 1.2 1.6 1.4 1.1 Gross NPAs Ratio 12.3 9.7 7.5 Adj. RoA.2 (.3).5.8 Adj. RoE 3.4 (5.8) 9.1 13. Share price 1 mth 3 mth 12 mth Absolute performance 1.4 2.7 (16.4) Relative to Nifty 1.4 (27.6) Shareholding Pattern Dec'17 Mar'18 Promoters 58.7 64. Institutions 33. 28. Retail 5.1 4.7 NBFC & Bodies Corporate 3.2 3.3 Total 1. 1. 1 Year Stock Price Performance 2 19 18 17 16 15 14 13 12 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Note: * CMP as on May 28, 218 Research Analyst : Asutosh Kumar Mishra Contact : (22) 3321323 Email : asutosh.mishra@relianceada.com 1

Risks to view Any major slowdown in economy may adversely impact the Bank s business growth and asset quality. Gradually intensifying competition in both Corporate & SME segments may drag loan book growth. Exhibit 1: Income Statement Analysis % yoy / bps % qoq / bps FY18 FY17 % yoy / bps Interest Inc. / Oper. Revenue 11,393 18,752 113,32 (2.3) 436,485 421,999 3.4 Global - Yield on Advances 7.9 7.13 (4) 7.15 (6) 7.13 7.27 (14) Global - Yield on Invt. 6.95 6.93 2 6.67 28 6.77 7.18 (41) Interest Expenses 7,37 72,933 (3.5) 69,92 1.8 281,268 286,865 (2.) Global - Cost of Dep. 4.5 4.7 (24) 4.4 7 4.5 4.8 (28) Net Interest Income 4,23 35,819 11.7 43,94 (8.9) 155,218 135,134 14.9 NII to Net Operative Income 7.2 64.4 581 72.4 (219) 7. 66.7 332 Global - NIM 2.5 2.2 34 2.7 (21) 2.4 2.2 24 Dom. NIM 2.9 2.5 42 3.2 (32) 2.9 2.6 24 Adjusted NII 35,833 3,958 15.7 37,727 (5.) 137,78 114,246 2.6 Core Fee Income 9,85 9,44 4.3 7,71 27.8 32,5 28,35 14.6 Trading Gains 2,87 6,77 (57.6) 5,9 (43.6) 19,94 26,19 (23.9) Profit on Exchange Transaction 1,7 1,84 (7.6) 2,13 (2.2) 7,92 9,76 (18.9) Recovery from PWO 2,539 1,723 47.4 1,8 4 6,212 3,281 89.3 Non Core Other Income 7,19 1,333 (31.2) 9,2 (21.2) 34,72 39,231 (13.2) Other Income - Total 16,959 19,773 (14.2) 16,73 1.4 66,572 67,581 () Other Inc to Net Oper. Income 29.8 35.6 (581) 27.6 219 3. 33.3 (332) Net Operating Revenue 56,982 55,591 2.5 6,671 (6.1) 221,789 22,715 9.4 Net Operating Revenue - Adj. 52,792 5,731 4.1 54,458 (3.1) 24,352 181,827 12.4 Employee Expenses 12,685 12,222 3.8 11,14 14.2 46,69 46,378 (.7) Empl. Cost/Oper. Exps. 22.3 22. 28 18.3 396 2.8 22.9 (211) Other Opex 17,642 13,167 34. 13,65 35. 55,665 46,586 19.5 Other Opex/ Assets.2.2 6.2 6.8.7 1 Total Opex 3,327 25,39 19.4 24,17 25.5 11,734 92,964 9.4 Cost to Income Ratio 53.2 45.7 755 39.8 1,338 45.9 45.9 1 Pre Provision Profits 26,655 3,22 (11.7) 36,51 (27.) 12,56 19,751 9.4 NPA & Bad Debts 7,53 24,25 19.8 31,55 123.5 142,12 76,79 85.1 Depreciation on Invest. (9,11) (83) 997.6 1,73 (626.6) (2,89) 19 (1,621.1) Standard Advances 3,32 2,55 3.2 93 257. 6,88 7,75 (11.2) Other Provisions 1,984 26 663.9 55 3,5.4 1,853 294 53.7 Provisions & Contingencies - Total 66,724 26,23 154.4 34,265 94.7 147,963 85,24 74. Credit Cost 6.58 - - 3. 354 3.48 1.89 159 NPA Provisions as % PPP 25.3 86.8 16,348 93.9 15,645 123.2 77.5 4,578 Profit Before Tax (4,69) 3,972 (1,18.8) 2,236 (1,892.) (27,97) 24,727 (212.9) Tax (9,46) 2,425 (473.) 1,118 (98.9) (3,589) 1,896 (132.9) Eective Tax Rate 22.6 6 (3,847) 5. (2,743.4) 12.9 44.1 (3,12) Reported Profits (31,23) 1,547 (2,15.1) 1,118 (2,875.4) (24,318) 13,831 (275.8) RoA (1.8).1 (187).1 (184.3) (.3) - - Basic EPS (Rs) (13.4).7 (2,2.).5 (2,788.) () 6. (275.5) Diluted EPS (Rs) (13.4).7 (2,2.).5 (2,788.) () 6. (275.5) 2

Exhibit 2: NII Trend Exhibit 3: Other Income Trend 5, 4, 2.3 2.1 2.2 2.2 2.3 2.1 2.2 2.1 2.3 2.7 2.5 3. 2.5 25, 2,.9.9 1.2.9 1.2 3, 2, 1, 1.7 2..5. 15, 1, 5,.5.6.6.9.6.3. Net Interest Income Global - NIM Other Income - Total Other Income / Assets Exhibit 4: Total OPEX Trend Exhibit 5: Pre Provision Profit Trend 35, 3, 25, 2, 15, 1, 5, 5.3 46.7 55.4 49.6 44.6 46.1 47.1 45.7 46.6 44.3 39.8 53.2 6. 5. 4. 3. 2. 1.. 4, 35, 3, 25, 2, 15, 1, 5, 1.2 1.3 1.6 1.6 1.8 1.6 1.8 2.1 2.5 2..5. Total Opex Cost to Income Ratio Pre Provision Profits Operating Profits / Assets Exhibit 6: Provision Expenses Trend Exhibit 7: Reported Profit Trend 8, 6, 4, 2, 27.2 8.9 361.7 266.6 75.1 66.8 8.1 86.8 89.4 76.6 93.9 25.3 4. 3. 2. 1. 2, 1, (1,) (2,) (3,).6.1-1.9-1.9.3.3.2.1.1.2.1-1.8.5. (.5) () () (2.). (4,) (2.5) Provisions & Contingencies - Total NPA Provisions as % PPP Reported Profits RoA 3

Exhibit 8: Balance Sheet Analysis QoQ % / bps YoY % / bps Net Worth 41,586 43,33 43,995 48,274 46,371 433,948 6.8 7.7 CET1 9.3 9. 8.8 8.4 8.3 9.2 95 25 Tier 1 1. 9.9 9.8 9.6 9.5 94 53 Total CAR 12.6 12.2 11.8 11.6 11.6 12.1 53 (11) RWA - Total 3,891,554 3,995,997 4,79,848 4,256,14 4,181,385 4,77,741 (2.5) 2. Advances - Total 3,499,61 3,832,592 3,776,67 3,873,16 3,993,88 4,274,318 7. 1 Investments 1,782,36 1,296,35 1,379,75 1,498,893 1,635,67 1,631,845 (.2) 25.9 Total Assets 6,869,482 6,948,754 6,643,752 6,769,158 6,828,243 7,199,998 5.4 3.6 RoA.2.1.12.21.7 (1.77) (184) (187) Deposits 5,898,589 6,16,752 5,76,75 5,832,12 5,732,652 5,913,148 3.1 (1.7) Saving Deposit 1,558,21 1,59,765 1,476,5 1,532,11 1,559,46 1,657,17 6.3 9.8 Current Deposit 44,15 425,193 46,75 417,24 425,41 46,62 8.3 8.3 CASA Deposits 1,962,36 1,934,958 1,882,8 1,949,35 1,984,87 2,117,79 6.7 9.4 CASA Ratio 4.5 38.8 38.8 39.2 4.6 41.2 61 239 Term Deposits 3,936,229 4,81,794 3,823,275 3,882,77 3,747,782 3,795,358 1.3 (7.) Interest Bearing Liabilities - Total 6,216,789 6,322,866 5,99,458 6,139,94 6,185,57 6,538,868 5.7 3.4 Exhibit 9: Loan Book Analysis QoQ % / bps YoY % / bps Home 265,48 31,69 329,39 353,8 383,18 447,11 16.7 48.2 Auto 42, 43,94 45,11 48, 52,18 57,27 9.8 3.3 Education 2,62 2,54 2,53 2,87 2,93 2,43 (2.4) (.5) Other Retail loans. 185,1 213,77 213,21 221,22 228,18 31,23 32. 4.9 Retail 475,63 541,172 571,975 589,15 64,149 826,4 29. 52.6 Agriculture 375,5 444,38 435,79 42,789 436,466 495,83 13.6 11.7 SME 425,56 541,172 544,738 476,894 465,563 517,3 11.1 (4.4) Large & Medium Corporate 1,2,158 1,221,16 1,143,95 1,29,42 1,338,494 1,647,83 23.1 34.9 Domestic Misc. 25,3 27,752 27,237 28,53 29,98 25,69 (11.7) (7.4) Gross Domestic Loan 2,5,33 2,775,24 2,723,69 2,85,26 2,99,77 3,512,69 2.7 26.6 Overseas 999,27 1,57,35 1,52,38 1,67,76 1,84,3 1,94,75 3.5 Advances - Total 3,499,61 3,832,592 3,776,67 3,873,16 3,993,88 4,274,318 7. 1 Exhibit 1: Funding Mix & Incremental Contribution As on As % of Total YoY/ YTD growth Incremental Contribution YoY/ YTD Growth FY15 FY16 FY17 FY18 Credit FY16 FY17 FY18 FY16 FY17 FY18 Deposits 6,175,595 5,74,379 6,16,752 5,913,148 9.4 (7.) 4.8 (1.7) 96. 11 (48.) Saving Deposit 1,11,722 1,167,54 1,59,765 1,657,17 25.3 5.9 29.4 9.8 (14.4) 138.3 68.2 Current Deposit 527,967 346,291 425,193 46,62 7. (34.4) 22.8 8.3 4.1 31.8 16.4 CASA Deposits 1,629,689 1,513,345 1,934,958 2,117,79 32.4 (7.1) 27.9 9.4 25.7 17.2 84.6 Term Deposits 4,545,97 4,227,34 4,81,794 3,795,358 58. (7.) (3.4) (7.) 7.4 (58.6) (132.6) Borrowings 352,643 334,717 36,114 625,72 9.6 (5.1) (8.5) 14.4 4. (1) 148. Interest Bearing Liabilities - Total 6,528,238 6,75,96 6,322,866 6,538,868 1. (6.9) 4.1 3.4 1. 1. 1. 4

Exhibit 11: Asset Quality Analysis QoQ % / bps YoY % / bps Total Slippages 41,35 4,77 52, 34,51 56,3 125,69 123.3 28.3 Slippages Ratio 8 6 1.36.9 1.47 3.28 181 222 Gross NPA 426,424 427,187 461,728 463,68 484,84 564,84 16.5 32.2 Gross NPAs Ratio 11.4 11.4 11.2 11.3 12.26 96 176 PCR - Calculated 55.4 57.7 57.7 57.7 59.1 58.4 (63) 75 PCR - Inc. Tech w/o 64.5 66.8 65. 67.2 68. 67.2 (82) 38 Net NPA 19,63 18,82 195,193 195,726 198,522 234,827 18.3 29.9 Net NPAs Ratio 5.4 4.7 5.2 5.1 5. 5.49 49 79 Std. Restructured / Watchlist 14,59 17,85 118,19 117,22 9,21 1,39 11.3 (6.9) Std. Restructured / Watchlist as % loan book 3.8 2.7 2.92 2.84 2.1 2.18 8 (47) 5

Profit & Loss Statement Y/E Mar FY17 FY18 FY19E FY2E Int. Income / Opr. Revenue 421,999 436,485 483,8 541,786 Interest Expenses 286,865 281,268 291,911 322,682 Net Interest Income 135,134 155,218 191,169 219,14 NIM 2.8 2.3 2.67 2.76 Other Income - Total 67,581 66,572 73,993 83,62 Net Operating Revenue 22,715 221,789 265,162 32,76 Employee Exp. 46,378 46,69 49,985 52,984 Other Opex 46,586 55,665 65,685 77,58 Total Opex 92,964 11,734 115,669 13,492 C/I Ratio 45.86 45.87 43.62 43.11 Pre Provision Profits 19,751 12,56 149,492 172,215 PPP Growth (yoy %) 24.5 9.4 24.5 15.2 Total Stress Loan Provision 76,79 142,12 85,486 72,61 Standard Assets Provision 7,75 6,88 2,832 3,146 Investment Depreciation 19 (2,89) 3,562 4,7 Other Provisions 294 1,853 2,131 2,387 Provisions & Contingencies - Tot 85,24 147,963 94,11 82,15 Credit Cost (As % of Op. AUM) 2. 3.71 2. Profit Before Tax 24,727 (27,97) 55,482 9,65 Tax 1,896 (3,589) 14,148 24,317 Eective Tax Rate 44.1 12.9 25.5 27. Reported Profits 13,831 (24,318) 41,334 65,747 PAT Growth (yoy %) (125.6) (275.8) (27.) 59.1 Balance Sheet Y/E March FY17 FY18 FY19E FY2E Equity Share Capital 4,621 5,34 5,34 5,34 Res. (ex Revel. Reserve) 362,652 397,81 438,415 5,969 Net Worth - Ex Revaluation 367,273 42,384 443,718 56,272 Revaluation Reserve 35,76 31,563 29,897 29,11 Deposits 6,16,752 5,913,148 6,459,19 7,38,28 Borrowings 36,114 625,72 697,798 767,168 Interest Bearing Liabi. 6,322,866 6,538,868 7,156,97 8,75,448 Other Lia. & Prov. 222,856 227,182 25,399 268,811 Total Liabilities 6,948,754 7,199,998 7,88,921 8,879,641 Assets Cash & Cash Equivalent 1,54,699 928,974 844,247 934,29 Investments 1,296,35 1,631,845 1,78,878 2,3,721 Loan & Advances 3,832,592 4,274,318 4,84,665 5,469,952 Growth (yoy %) (.1) 1 13.3 13. Fixed Assets 57,584 53,674 56,489 61,114 Other Assets 257,574 311,186 358,642 41,645 Total Assets 6,948,754 7,199,998 7,88,921 8,879,641 6

Per Share Data Y/E Mar FY17 FY18 FY19E FY2E Face Value (Rs) 2 2 2 2 Adjusted Share O/S (mn) 2,31 2,652 2,652 2,652 Earnings Per Share (Rs) 6. (9.2) 15.6 24.8 EPS (% YoY) (125.6) (253.2) (27.) 59.1 P/E (x) 24.3-15.8 9.3 5.9 Adj. EPS (Rs) 6. (9.2) 15.6 24.8 Adj. EPS (% YoY) (125.6) (253.2) (27.) 59.1 Adj. Price-Earnings (x) 24.3-15.8 9.3 5.9 Book Value (Rs) 159. 151.7 167.3 19.9 BVPS (% YoY) 1.8 (4.5) 1.3 14.1 P/BV (x).9.9.8 Detail RoA Tree Analysis Y/E Mar FY17 FY18 FY19E FY2E Yields / Margins Yield on Advance 7.2 7.2 7.3 7.3 Yield on Funds 6.5 6.5 6.8 6.8 Cost of Funds (CoF) 4.6 4.4 4.3 4.2 Interest Spread 1.9 2.1 2.5 2.6 NIM's 2.1 2.3 2.7 2.8 Interest Income / Assets 6.2 6.2 6.4 6.5 Interest Exp. / Assets 4.2 4. 3.9 3.9 NII / Assets 2. 2.2 2.5 2.6 Fee Income / Assets.4.5.5.5 Other Non Core Income / Assets.4.3.3.2 Other Income / Assets.9 Net Operating Income / Assets 3. 3.1 3.5 3.6 Operating Ratios NII to Net Operative Income 66.7 7. 72.1 72.4 Other Inc. to Net Operative Income 33.3 3. 27.9 27.6 Empl. Cost/Oper. Exps. 49.9 45.3 43.2 4.6 Other Op. Exps./Oper. Exps. 5.1 54.7 56.8 59.4 C/I Ratio 45.9 45.9 43.6 43.1 Provisions as % PPP 41.9 66.7 35.5 27.1 Credit Cost (As % of Op. AUM) 2. 3.7 2. Eective Tax Rate 44.1 12.9 25.5 27. Employee Exp. / Assets.7.7.7.6 Other Opex/ Assets.7.8.9.9 Total Opex / Assets 1.4 1.4 1.6 Operating Profits / Assets 1.6 1.7 2. 2.1 Provisions / Assets 1.2 2.1 1.2 Profit Before Tax / Assets.4 (.4).7 1.1 Tax Expenses / Assets.2 (.1).2.3 RoA.2 (.3).5.8 Leverage (x) 18.9 17.9 17.8 17.5 RoE 3.4 (5.8) 9.1 13. 7

Balance Sheet Ratio Y/E Mar FY17 FY18 FY19E FY2E Credit / Deposit Ratio 63.7 72.3 74.9 74.8 Incremental C/D Ratio (1.8) (426.4) 13.7 74.1 Investment Deposit Ratio 2 27.6 27.6 27.4 Dom. SLR Investment / Deposits 25.2 28.9 31.2 3.6 CASA Ratio 44. 45.4 46. 46.3 Credit Quality Y/E Mar FY17 FY18 FY19E FY2E Slippage Ratio 3.5 6.3 3.3 2. Gross NPA 427,187 564,84 471,898 412,295 Gross NPAs Ratio 12.3 9.7 7.5 PCR 57.7 58.4 57.4 56.7 Net NPA 18,82 234,827 21,84 178,561 Net NPAs Ratio 4.7 5.5 4.2 3.3 Total Impaired Loans 431,459 576,1 471,898 412,295 Impaired Loan as % of Loan / AUM 1 13.1 9.5 7.3 Total Risk Reserves 246,385 329,977 27,814 233,735 Total Risk As % of Loan Book 6.3 7.5 5.4 4.1 Capital and Asset-Liability Profile Y/E Mar FY17 FY18 FY19E FY2E Total RWAs 3,995,997 4,77,741 4,535,467 5,36,322 RWA as % of Total Assets 57.5 56.6 57.5 56.7 Shareholders Equ. to Assets (x) 5.3 5.6 5.6 5.7 CET 1 Ratio 9. 9.2 9.2 9.4 AT 1 Ratio.9 1.2 1.2 1.2 Tier 1 Ratio 9.9 1.4 1.6 Tier 2 Ratio 2.3 1.7 1.7 1.6 Total CRAR Ratio 12.2 12.1 12. 12.2 8

Rating Guides Rating Expected absolute returns over 12 months >1% HOLD -5% to 1% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 214 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/ opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U6599MH25PLC15452. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 11234839, Depository Participants: CDSL IN-DP-257-216 IN-DP-NSDL-363-213, Research Analyst: INH2384); AMFI ARN No.29889. 9